LNAI supply chain intelligence for Lunai Bioworks Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| ONCOTELIC | ONCOTELIC | 90% | The Series B Preferred Stock was allocated five (5) shares to Oncotelic (representing 62.5% of the Series B Preferred Stock and an aggregate Stated Value of $12,500,000) |
| PELERIN | PELERIN | 90% | The Series B Preferred Stock was allocated three (3) shares to Pelerin (representing 37.5% of the Series B Preferred Stock and an aggregate Stated Value of $7,500,000) |
| ORANY | ORANY | 72% | ow Renovaro Cube to control the sample preparation and medical device, thereby enabling faster commercialization analysis and quality control; and ● Expand its team to include biomedical scientists, … |
| ORANY | ORANY | 72% | Reciprocal relationship from ORANY graph: Reciprocal relationship from LNAI graph: ow Renovaro Cube to control the sample preparation and medical device, thereby enabling faster commercialization ana… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| CLEMANN-GROUP | CLEMANN-GROUP | 92% | The Transaction is structured as a $20.0 million strategic investment in the Company in the form of Series B Convertible Preferred Stock |
| KAPOOSE-CREEK-BIO | KAPOOSE-CREEK-BIO | 92% | During the three months ended March 31, 2026, the Company, through its wholly owned subsidiary BioSymetrics Corporation (Canada), entered into a research services agreement with Kapoose Creek Bio (th… |
| ORANY | ORANY | 72% | ow Renovaro Cube to control the sample preparation and medical device, thereby enabling faster commercialization analysis and quality control; and ● Expand its team to include biomedical scientists, … |
| ORANY | ORANY | 72% | Reciprocal relationship from ORANY graph: Reciprocal relationship from LNAI graph: ow Renovaro Cube to control the sample preparation and medical device, thereby enabling faster commercialization ana… |
| ASSOCIATES-LLC | ASSOCIATES-LLC | 62% | extent of effort when performing audit procedures to evaluate the reasonableness of such estimates and assumptions. Our audit procedures related to the following: ● In relation to the GediCube goodwi… |
| GEDICUBE-INTL-LTD | GEDICUBE-INTL-LTD | 62% | extent of effort when performing audit procedures to evaluate the reasonableness of such estimates and assumptions. Our audit procedures related to the following: ● In relation to the GediCube goodwi… |
| PLAZA-MEDICAL-OFFICE-BUILDING-LLC | PLAZA-MEDICAL-OFFICE-BUILDING-LLC | 62% | e Agreement On June 20, 2022, the Company entered into a sublease Agreement with One Health Labs (the “Subtenant”), whereby the Subtenant agreed to lease 3,554 square feet of space currently rented b… |
| RENOVARO-CUBE-INTL-LTD | RENOVARO-CUBE-INTL-LTD | 62% | have the same effect, thus complicating compliance efforts. If our operations are found to be in violation of any of such laws or any other governmental laws or regulations that apply, they may be su… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| LNAI-DEBT-10738 | Warrants outstanding: 3425399 | 90% | xbrl warrant detail from xbrl 2024-06-30. |
| LNAI-DEBT | Debt stack $2.8M | 90% | Market cache reports total debt of $2.8M. |
| LNAI-DEBT-10739 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2025-12-31. |
| Acquired Entity | Name | Confidence | Evidence |
|---|---|---|---|
| LNAI-ACQ-0001731122-26-000502 | The Company entered into a binding agreement to acquire technology through a $20 million strateg... | 85% | The Company entered into a binding agreement to acquire technology through a $20 million strategic investment in the form of Series B Convertible Preferred Stock. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| LNAI-OWNER-NORTHERN-TRUST-CORPORATION | Northern Trust Corporation | 95% | 13F/ownership overlay lists Northern Trust Corporation; shares held 37,402; ownership 0.15%; value $15,439; as of 2025-12-31. |
| LNAI-OWNER-VANGUARD-GROUP-INC | Vanguard Group Inc | 95% | 13F/ownership overlay lists Vanguard Group Inc; shares held 497,011; ownership 2.05%; value $205,166; as of 2025-12-31. |
| LNAI-OWNER-STATE-STREET-CORPORATION | State Street Corporation | 95% | 13F/ownership overlay lists State Street Corporation; shares held 35,728; ownership 0.15%; value $14,748; as of 2025-12-31. |
| LNAI-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC | Geode Capital Management, LLC | 95% | 13F/ownership overlay lists Geode Capital Management, LLC; shares held 131,015; ownership 0.54%; value $54,082; as of 2025-12-31. |
| LNAI-OWNER-BLACKROCK-INC | Blackrock Inc. | 95% | 13F/ownership overlay lists Blackrock Inc.; shares held 127,314; ownership 0.53%; value $52,555; as of 2025-12-31. |
| LNAI-OWNER-NINE-MASTS-CAPITAL-LTD | Nine Masts Capital Ltd. | 95% | 13F/ownership overlay lists Nine Masts Capital Ltd.; shares held 24,220; ownership 0.10%; value $9,998; as of 2025-12-31. |
| LNAI-OWNER-CITADEL-ADVISORS-LLC | Citadel Advisors Llc | 95% | 13F/ownership overlay lists Citadel Advisors Llc; shares held 20,632; ownership 0.09%; value $8,516; as of 2025-12-31. |
| LNAI-OWNER-UBS-GROUP-AG | UBS Group AG | 95% | 13F/ownership overlay lists UBS Group AG; shares held 17,940; ownership 0.07%; value $7,405; as of 2025-12-31. |
| LNAI-OWNER-JANE-STREET-GROUP-LLC | Jane Street Group, LLC | 95% | 13F/ownership overlay lists Jane Street Group, LLC; shares held 11,900; ownership 0.05%; value $4,912; as of 2025-12-31. |
| LNAI-OWNER-MILLENNIUM-MANAGEMENT-LLC | Millennium Management Llc | 95% | 13F/ownership overlay lists Millennium Management Llc; shares held 166,744; ownership 0.69%; value $68,831; as of 2025-12-31. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| ORANY | ORANGE | 100.00 | 1 | ['customer', 'supplier'] |
| AMZE | Amaze Holdings, Inc. | 50.00 | 2 | |
| DWTX | Dogwood Therapeutics, Inc. | 50.00 | 2 | |
| CPRX | Catalyst Pharmaceuticals, Inc. | 50.00 | 2 | |
| AYTU | Aytu BioPharma, Inc. | 50.00 | 2 | |
| D | Dominion Energy, Inc. | 50.00 | 2 | |
| DARE | Daré Bioscience, Inc. | 50.00 | 2 | |
| CANF | Can-Fite BioPharma Ltd. | 50.00 | 2 | |
| DFTX | Definium Therapeutics, Inc. | 50.00 | 2 | |
| CHUC | Charlie's Holdings, Inc. | 50.00 | 2 | |
| CLNE | Clean Energy Fuels Corp. | 50.00 | 2 | |
| FENC | Fennec Pharmaceuticals Inc. | 50.00 | 2 | |
| EQR | Equity Residential | 50.00 | 2 | |
| CNOB | ConnectOne Bancorp, Inc. | 50.00 | 2 | |
| CYCN | Cyclerion Therapeutics, Inc. | 50.00 | 2 | |
| ESS | Essex Property Trust, Inc. | 50.00 | 2 | |
| ED | Consolidated Edison, Inc. | 50.00 | 2 | |
| SCNX | Scienture Holdings, Inc. | 50.00 | 2 | |
| CORT | Corcept Therapeutics Incorporated | 50.00 | 2 | |
| BLTE | Belite Bio, Inc | 50.00 | 2 |